Close
Back to IMCL Stock Lookup

Immunoclin Corporation (IMCL) – Press Releases

Mar 10, 2017 08:45 AM Spotlight Innovation Commences Part 2 of Phase I Cancer Trial
Dec 15, 2015 07:53 AM After Successful Formulation Work, Cannabis Science Follows Through With a Full Clinical Drug Development Agreement With ImmunoClin to Deliver GMP Quality Pre-Clinical Data to Enter CS-NEURO-1 Into a
Aug 24, 2015 08:00 AM Spotlight Innovation Subsidiary Celtic Biotech Prepares to Start Part 2 of Phase I Intravenous Crotoxin Clinical Study
May 20, 2015 12:39 PM ImmunoClin Ltd. to Provide Contract Research Organization (CRO) Services for Crotoxin Phase I Part II Clinical Trials for Spotlight Innovation Subsidiary Celtic Biotech
Apr 2, 2015 12:51 PM Subsidiary of ImmunoClin Corporation (IMCL) receives controlled drug license in the United Kingdom
Mar 10, 2015 10:29 AM ImmunoClin Corporation (IMCL) Relocates European Headquarters and Laboratories to London, UK

Back to IMCL Stock Lookup